Skip to content
Safety information · Internal patient-safety page

Dutasteride safety summary

Dutasteride blocks both type-I and type-II 5α-reductase, lowering DHT more completely than finasteride. It is used for androgenetic alopecia in men when a stronger anti-androgen response is appropriate, and for benign prostatic hyperplasia.

Dutasteride 0.5mg

What it's used for

  • 0.5 mg orally once a day, with or without food.
  • Half-life is long (3–5 weeks): plasma levels persist after stopping, side effects can take time to resolve.
  • Stopping treatment reverses hair-loss gains over 6–12 months.

Most common side effects

  • Decreased libido.
  • Erectile dysfunction.
  • Ejaculation disorders.
  • Breast tenderness or enlargement (gynaecomastia).
  • Mood changes: including low mood.

Serious side effects: stop and seek care

  • Depressive symptoms or suicidal thoughts: stop and seek care.
  • Breast lumps, pain or nipple discharge.
  • Severe allergic reaction (angio-oedema).
  • Persistent sexual side effects after stopping treatment.

Who should not take it

  • Women, especially during pregnancy or planning pregnancy: dutasteride causes feminisation of male foetuses and is absorbed through the skin.
  • Children and adolescents under 18.
  • Known hypersensitivity to dutasteride or other 5α-reductase inhibitors.
  • Severe liver impairment.

Interactions to flag

  • Strong CYP3A4 inhibitors (ritonavir, ketoconazole, itraconazole, clarithromycin): can raise dutasteride levels; the doctor may consider an alternate-day schedule.
  • Other 5α-reductase inhibitors (finasteride): never combine.
  • PSA testing: dutasteride lowers PSA by ~50%; tell any clinician running a PSA test you take it.
  • Blood donation: do not donate blood while on dutasteride and for 6 months after stopping.

Message us in the app chat if you notice any of these

  • Persistent low mood or thoughts of self-harm: stop the medicine and contact us same day.
  • Sexual side effects that don't settle within a few months.
  • Any breast change (lumps, pain, discharge).
  • Pregnancy in your partner: capsules should not be handled by pregnant women.
AEMPS CIMA: Dutasteride 0.5 mg

This page summarises information from the regulator-approved leaflet for reference only. It does not replace the full leaflet, linked on this page, it is not medical advice and it does not replace the assessment of an EU-licensed doctor. Your doctor will review your individual history, dose and interactions during your consultation.

Back to your consultation